FindTrial
Sign In

Analysis of Risk Factors for Rebleeding Within 6 Weeks After Endoscopic Variceal Ligation in Patients With Cirrhosis

Analysis of Risk Factors for Rebleeding Within 6 Weeks After Endoscopic Variceal Ligation in Patients With Cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116560
Enrollment
Unknown
Registered
2026-01-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal and gastric varices

Interventions

Observation Group of Esophageal and Gastric Varices:None

Sponsors

The First Afilliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The presence of liver cirrhosis is confirmed through clinical manifestations, imaging examinations, laboratory tests and liver biopsy, etc. 2. Endoscopic examination confirmed the presence of EV.

Exclusion criteria

Exclusion criteria: 1. Non-liver cirrhosis; 2. Prophylactic repeated EVL treatment within 6 weeks after the operation; 3. Previously received transjugular intrahepatic portosystemic shunt Treatments such as TIPS, balloon-occluded retrograde transvenous obliteration (BRTO), etc. 4. Loss of clinical data or failure to follow up.

Design outcomes

Primary

MeasureTime frame
Whether bleeding recurs within 6 weeks;Prothrombin Time;Hemoglobin;Total Bilirubin;Blood platelet;Albumin;Alanine Aminotransferase;—

Countries

China

Contacts

Public ContactZhang Peihong

The First Afilliated Hospital of Fujian Medical University

1484640974@qq.com+86 591 8798 1230

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026